Literature DB >> 9218649

Interim guidelines for prevention and control of Staphylococcal infection associated with reduced susceptibility to vancomycin.

.   

Abstract

Staphylococci are one of the most common causes of community- and hospital-acquired infection. In many U.S. hospitals, strains of staphylococci (i.e., Staphylococcus aureus or coagulase-negative staphylococci) are resistant to all available antimicrobials except vancomycin. Rare cases of infection in the United States (1) have been caused by coagulase-negative staphylococci with reduced susceptibility to vancomycin (minimum inhibitory concentration [MIC] > or = 8 microg/mL)(2).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218649

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  34 in total

Review 1.  Update in internal medicine.

Authors:  F López-Jiménez; M Brito; Y W Aude; P Scheinberg; M Kaplan; D A Dixon; N Schneiderman; J F Trejo; L H López-Salazar; E J Ramírez-Barba; R Kalil; C Ortiz; J Goyos; A Buenaño; S Kottiech; G A Lamas
Journal:  Arch Med Res       Date:  2000 Jul-Aug       Impact factor: 2.235

Review 2.  Relationships between enterococcal virulence and antimicrobial resistance.

Authors:  L M Mundy; D F Sahm; M Gilmore
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

3.  Antimicrobial resistance takes another step forward.

Authors:  James Maskalyk
Journal:  CMAJ       Date:  2002-08-20       Impact factor: 8.262

4.  Evaluation of non-automated techniques for phenotypic detection of VanA-type Staphylococcus aureus.

Authors:  C Girard-Blanc; P Courvalin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

5.  VISA, hetero-VISA and VRSA: the end of the vancomycin era?

Authors:  John M Conly; B Lynn Johnston
Journal:  Can J Infect Dis       Date:  2002-09

6.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

7.  Community-based parenteral anti-infective therapy (CoPAT). Pharmacokinetic and monitoring issues.

Authors:  D N Williams; J L Raymond
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

8.  The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance.

Authors:  D J Austin; K G Kristinsson; R M Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

9.  Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations.

Authors:  R L Akins; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

10.  Laboratory reporting of Staphylococcus aureus with reduced susceptibility to vancomycin in United States Department of Veterans Affairs facilities.

Authors:  Stephen M Kralovic; Linda H Danko; Gary A Roselle
Journal:  Emerg Infect Dis       Date:  2002-04       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.